BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

100 related articles for article (PubMed ID: 24812482)

  • 21. Human papillomavirus genotype distribution and E6/E7 oncogene expression in Turkish women with cervical cytological findings.
    Tezcan S; Ozgur D; Ulger M; Aslan G; Gurses I; Serin MS; Giray BG; Dilek S; Emekdas G
    Asian Pac J Cancer Prev; 2014; 15(9):3997-4003. PubMed ID: 24935586
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Human papillomavirus detection in cervical lesions nondiagnostic for cervical intraepithelial neoplasia: correlation with Papanicolaou smear, colposcopy, and occurrence of cervical intraepithelial neoplasia.
    Nuovo GJ; Blanco JS; Leipzig S; Smith D
    Obstet Gynecol; 1990 Jun; 75(6):1006-11. PubMed ID: 2160630
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Quantitation of human papillomavirus 16 E6 and E7 DNA and RNA in residual material from ThinPrep Papanicolaou tests using real-time polymerase chain reaction analysis.
    Wang-Johanning F; Lu DW; Wang Y; Johnson MR; Johanning GL
    Cancer; 2002 Apr; 94(8):2199-210. PubMed ID: 12001118
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Outcome of expectant management of cervical intraepithelial neoplasia grade 2 in women followed for 12 months.
    Discacciati MG; de Souza CA; d'Otavianno MG; Ângelo-Andrade LA; Westin MC; Rabelo-Santos SH; Zeferino LC
    Eur J Obstet Gynecol Reprod Biol; 2011 Apr; 155(2):204-8. PubMed ID: 21193261
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Aptima HPV E6/E7 mRNA test is as sensitive as Hybrid Capture 2 Assay but more specific at detecting cervical precancer and cancer.
    Ratnam S; Coutlee F; Fontaine D; Bentley J; Escott N; Ghatage P; Gadag V; Holloway G; Bartellas E; Kum N; Giede C; Lear A
    J Clin Microbiol; 2011 Feb; 49(2):557-64. PubMed ID: 21147950
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Prevalence, correlates, and predictive value of high-risk human papillomavirus mRNA detection in a community-based cervical cancer screening program in western Uganda.
    Nakalembe M; Makanga P; Mubiru F; Swanson M; Martin J; Huchko M
    Infect Agent Cancer; 2019; 14():14. PubMed ID: 31114629
    [TBL] [Abstract][Full Text] [Related]  

  • 27. HPV detection and measurement of HPV-16, telomerase, and survivin transcripts in colposcopy clinic patients.
    Lanham S; Herbert A; Watt P
    J Clin Pathol; 2001 Apr; 54(4):304-8. PubMed ID: 11304848
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Phylogeny and polymorphism in the E6 and E7 of human papillomavirus: alpha-9 (HPV16, 31, 33, 52, 58), alpha-5 (HPV51), alpha-6 (HPV53, 66), alpha-7 (HPV18, 39, 59, 68) and alpha-10 (HPV6, 44) in women from Shanghai.
    Zhao J; Zhan Q; Guo J; Liu M; Ruan Y; Zhu T; Han L; Li F
    Infect Agent Cancer; 2019; 14():38. PubMed ID: 31832087
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Evaluation of HPV E6/E7 mRNA Detection in Clinically Suspected Cases of Cervical Cancer with Abnormal Cytology: Time to Upgrade the Screening Protocols.
    Sharma B; Lakhanpal V; Singh K; Oberoi L; Bedi PK; Devi P
    J Lab Physicians; 2022 Sep; 14(3):336-342. PubMed ID: 36119422
    [No Abstract]   [Full Text] [Related]  

  • 30. Performance of Aptima HPV E6/E7 mRNA Test for Detection of Cervical Lesions in a Large Chinese Population.
    Yang Z; Zhu W; Liu Y; Chen X
    Iran J Public Health; 2022 Nov; 51(11):2549-2554. PubMed ID: 36561247
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Effect of Condom Use after CIN Treatment on Cervical HPV Biomarkers Positivity: Prolonged Follow Up Study.
    Valasoulis G; Michail G; Pouliakis A; Androutsopoulos G; Panayiotides IG; Kyrgiou M; Daponte A; Paraskevaidis E
    Cancers (Basel); 2022 Jul; 14(14):. PubMed ID: 35884589
    [TBL] [Abstract][Full Text] [Related]  

  • 32. HPV 16 Is Related to the Progression of Cervical Intraepithelial Neoplasia Grade 2: A Case Series.
    Loffredo D'Ottaviano MG; Discacciati MG; Andreoli MA; Costa MC; Termini L; Rabelo-Santos SH; Villa LL; Zeferino LC
    Obstet Gynecol Int; 2013; 2013():328909. PubMed ID: 24369469
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Heat shock fusion protein-based immunotherapy for treatment of cervical intraepithelial neoplasia III.
    Einstein MH; Kadish AS; Burk RD; Kim MY; Wadler S; Streicher H; Goldberg GL; Runowicz CD
    Gynecol Oncol; 2007 Sep; 106(3):453-60. PubMed ID: 17586030
    [TBL] [Abstract][Full Text] [Related]  

  • 34. HPV infection associated DNA damage correlated with cervical precancerous lesions and cancer in the highest area of cervical cancer mortality, Longnan, China.
    Zhao J; Guo Z; Wang Q; Si T; Pei S; Qu H; Shang L; Yang Y; Wang L
    Cancer Manag Res; 2019; 11():7197-7210. PubMed ID: 31534369
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Diagnostic value of HPV E6/E7 mRNA in screening for cervical intraepithelial neoplasia grade 2 or worse: A systematic review and meta‑analysis.
    Xu F; Ran T; Wei Q; Pan R; Chen S; Luo J
    Oncol Lett; 2024 May; 27(5):231. PubMed ID: 38586199
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Overexpression of E6/E7 mRNA HPV Is a Prognostic Biomarker for Residual Disease Progression in Women Undergoing LEEP for Cervical Intraepithelial Neoplasia 3.
    Bruno MT; Bonanno G; Sgalambro F; Cavallaro A; Boemi S
    Cancers (Basel); 2023 Aug; 15(17):. PubMed ID: 37686479
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Evaluation of the Therapeutic Effect of Quadrivalent Human Papillomavirus (HPV) Vaccination on Cervical Intraepithelial Neoplasia Lesions.
    Shiravani Z; Nazari Z; Yazdani F; Najib FS; Jahromi MA; Momtahan M; Pourseyed S; Moradialamdarloo S; Tafti MH
    Indian J Surg Oncol; 2023 Jun; 14(2):504-509. PubMed ID: 37324297
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Diagnostic validity of p16, E-cadherin, cyclin D1, p53, and HPV E6/E7 mRNA in CIN 3-like squamous cell carcinoma of the cervix.
    Xing Z; Danhua S; Xiaobo Z
    Front Oncol; 2024; 14():1354838. PubMed ID: 38344198
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Active expectancy as alternative to treatment for cervical intraepithelial neoplasia grade 2 in women aged 25 to 30 years: ExCIN2-a prospective clinical multicenter cohort study.
    Kylebäck K; Ekeryd-Andalen A; Greppe C; Björkenfeldt Havel C; Zhang C; Strander B
    Am J Obstet Gynecol; 2022 Nov; 227(5):742.e1-742.e11. PubMed ID: 35777432
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Regression rate of high-grade cervical intraepithelial lesions in women younger than 25 years.
    Ehret A; Bark VN; Mondal A; Fehm TN; Hampl M
    Arch Gynecol Obstet; 2023 Mar; 307(3):981-990. PubMed ID: 35861859
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.